{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:16:21Z","timestamp":1778991381034,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jaad.2013.04.041","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T02:08:56Z","timestamp":1384222136000},"page":"S57-S65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Emerging therapies in rosacea"],"prefix":"10.1016","volume":"69","author":[{"given":"Alison","family":"Layton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.04.041_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"van Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/08959374980120012001","article-title":"The potential role of doxycycline in the treatment of osteoarthritis of the temporomandibular joint","volume":"12","author":"Israel","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2013.04.041_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1902\/jop.2008.080051","article-title":"Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex\u00a0vivo human whole blood models","volume":"79","author":"Cazalis","year":"2008","journal-title":"J Periodontol"},{"key":"10.1016\/j.jaad.2013.04.041_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0266-4356(94)90137-6","article-title":"Effects of antibiotics on human polymorphonuclear leukocyte chemotaxis in\u00a0vitro","volume":"32","author":"Ueyama","year":"1994","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaad.2013.04.041_bib8","first-page":"1807","article-title":"Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2","volume":"25","author":"Pruzanski","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.176.1.567","article-title":"Doxycycline modulates nitric oxide production in murine lung epithelial cells","volume":"176","author":"Hoyt","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.04.041_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2340\/0001555572178179","article-title":"Effect of doxycycline on the generation of reactive oxygen species: a possible mechanism of action of acne therapy with doxycycline","volume":"72","author":"Akamatsu","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.04.041_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","article-title":"Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis","volume":"33","author":"Dan","year":"2008","journal-title":"Curr Eye Res"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.04.041_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the global alliance to improve outcomes in acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/jid.2012.14","article-title":"Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin","volume":"132","author":"Kanada","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12019-007-8003-x","article-title":"Submicrobial doxycycline and rosacea","volume":"33","author":"Wise","year":"2007","journal-title":"Compr Ther"},{"key":"10.1016\/j.jaad.2013.04.041_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1902\/jop.2008.070375","article-title":"Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease","volume":"79","author":"Preshaw","year":"2008","journal-title":"J Periodontol"},{"key":"10.1016\/j.jaad.2013.04.041_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0765.1990.tb00923.x","article-title":"Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans","volume":"25","author":"Golub","year":"1990","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.jaad.2013.04.041_bib17","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.04.041_bib18","first-page":"7","article-title":"An open label, community based, 12 week assessment of the effectiveness and safety of monotherapy with doxycycline 40mg (30mg immediate release and 10mg delayed release beads)","volume":"86","author":"Webster","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.04.041_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2005.07.021","article-title":"Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol","volume":"53","author":"Craige","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","article-title":"Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker","volume":"67","author":"Hsu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archdermatol.2011.204","article-title":"Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea","volume":"147","author":"Hsu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib22","first-page":"149","article-title":"Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin","volume":"80","author":"Allen","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.04.041_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000066430","article-title":"Ivermectin-responsive Demodex infestation during human immunodeficiency virus infection: a case report and literature review","volume":"205","author":"Aquilina","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.04.041_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0151-9638(05)79308-X","article-title":"Demodecie chez un malade infecte par le VIH: guerison pas ivermectine","volume":"132","author":"Clyti","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.04.041_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0190-9622(99)70022-8","article-title":"Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream","volume":"41","author":"Forstinger","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1365-4632.2006.02924.x","article-title":"Ivermectin treatment of three cases of demodecidosis during human immunodeficiency virus infection","volume":"45","author":"Clyti","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea, I: etiology, pathogenesis and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib28","first-page":"663","article-title":"The pathophysiology of rosacea","volume":"144","author":"McAleer","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.04.041_bib29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2133.1993.tb00261.x","article-title":"Density of Demodex folliculorum in rosacea: a case control study using standardized skin surface biopsy","volume":"128","author":"Forton","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1346-8138.2004.tb00567.x","article-title":"The clinical importance of Demodex folliculorum presenting with nonspecific facial signs and symptoms","volume":"31","author":"Karincaoglu","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1473-3099(08)70283-4","article-title":"Rosacea-like demodicidosis","volume":"8","author":"Larios","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2013.04.041_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-4632.2010.04495.x","article-title":"Dermoscopy as a diagnostic tool in demodicidosis","volume":"49","author":"Segal","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib33","first-page":"20","article-title":"Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton","volume":"2","author":"Bikowski","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1468-3083.2005.01221.x","article-title":"Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea?","volume":"19","author":"Bonamigo","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.04.041_bib35","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaad.2009.01.029","article-title":"Rosaceiform dermatitis associated with topical tacrolimus treatment","volume":"62","author":"Fujiwara","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000323001","article-title":"Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors","volume":"222","author":"Gerber","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.04.041_bib37","first-page":"25","article-title":"The cutaneous environment in papulopustular rosacea","volume":"161","author":"Ni Raghallaigh","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib38","first-page":"S65","article-title":"The fatty acid profile of the skin surface lipid layer in patients with papulopustular rosacea","volume":"130","author":"Ni Raghallaigh","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0190-9622(89)70021-9","article-title":"Papulonodular demodicidosis associated with acquired immunodeficiency syndrome","volume":"20","author":"Dominey","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(95)70168-0","article-title":"Demodicidosis in childhood acute lymphoblastic leukemia: an opportunistic infection occurring with immunosuppression","volume":"127","author":"Ivy","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.04.041_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/08860220500198037","article-title":"Incidence of Demodex folliculorum in patients with end-stage chronic renal failure","volume":"27","author":"Karincaoglu","year":"2005","journal-title":"Ren Fail"},{"key":"10.1016\/j.jaad.2013.04.041_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-4632.2007.03336.x","article-title":"Clinical importance of Demodex folliculorum in patients receiving phototherapy","volume":"47","author":"Kulac","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib43","first-page":"896","article-title":"Retrospective analysis of the association between Demodex infestation and rosacea","volume":"146","author":"Zhao","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2133.2008.08437.x","article-title":"Skin microbiota: a source of disease or defense?","volume":"158","author":"Cogen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.2007.08028.x","article-title":"Mite-related bacterial antigens stimulate inflammatory cells in rosacea","volume":"157","author":"Lacey","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib46","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2133.2012.11114.x","article-title":"Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea","volume":"167","author":"O'Reilly","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.041_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4103\/0378-6323.100571","article-title":"Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies","volume":"78","author":"Chhaiya","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2013.04.041_bib48","unstructured":"US National Institutes of Health. Clinicaltrials.gov. Available at: http:\/\/www.clinicaltrialsgov.com. Accessed October 1, 2012."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:18Z","timestamp":1759271358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213004337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0190962213004337"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.041","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapies in rosacea","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}